Global Medical REIT (NYSE:XRN) COO Danica Holley Acquires 1,490 Shares of Stock

Global Medical REIT Inc. (NYSE:XRNGet Free Report) COO Danica Holley bought 1,490 shares of the business’s stock in a transaction that occurred on Tuesday, May 12th. The shares were purchased at an average price of $33.99 per share, for a total transaction of $50,645.10. Following the completion of the purchase, the chief operating officer directly owned 1,590 shares of the company’s stock, valued at approximately $54,044.10. This trade represents a 1,490.00% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink.

Global Medical REIT Price Performance

Shares of XRN opened at $34.11 on Wednesday. The firm has a market capitalization of $451.21 million, a price-to-earnings ratio of -30.73 and a beta of 1.11. The firm’s fifty day simple moving average is $35.04 and its 200-day simple moving average is $34.44. Global Medical REIT Inc. has a twelve month low of $29.05 and a twelve month high of $39.93. The company has a current ratio of 0.68, a quick ratio of 0.61 and a debt-to-equity ratio of 1.68.

Global Medical REIT Announces Dividend

The firm also recently declared a monthly dividend, which will be paid on Friday, September 18th. Shareholders of record on Thursday, August 20th will be issued a dividend of $0.16 per share. This represents a c) dividend on an annualized basis and a yield of 5.6%. The ex-dividend date of this dividend is Thursday, August 20th. Global Medical REIT’s payout ratio is -270.27%.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on XRN shares. Weiss Ratings downgraded Global Medical REIT from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday. Compass Point reaffirmed a “neutral” rating and issued a $38.00 price target (down from $50.00) on shares of Global Medical REIT in a report on Thursday, May 7th. Finally, Wall Street Zen cut shares of Global Medical REIT from a “hold” rating to a “sell” rating in a report on Saturday. One research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $39.67.

Get Our Latest Stock Report on Global Medical REIT

Institutional Trading of Global Medical REIT

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Invesco Ltd. raised its stake in shares of Global Medical REIT by 4.2% during the fourth quarter. Invesco Ltd. now owns 310,432 shares of the company’s stock worth $10,474,000 after purchasing an additional 12,471 shares during the last quarter. Mackenzie Financial Corp acquired a new stake in shares of Global Medical REIT in the 4th quarter worth $563,000. XTX Topco Ltd purchased a new stake in shares of Global Medical REIT in the fourth quarter valued at about $515,000. Tudor Investment Corp ET AL purchased a new stake in shares of Global Medical REIT in the fourth quarter valued at about $930,000. Finally, Clifford Capital Partners LLC increased its stake in shares of Global Medical REIT by 31.3% during the fourth quarter. Clifford Capital Partners LLC now owns 14,694 shares of the company’s stock worth $496,000 after acquiring an additional 3,504 shares during the period. 57.52% of the stock is owned by hedge funds and other institutional investors.

About Global Medical REIT

(Get Free Report)

Global Medical REIT (NYSE: GMRE) is a real estate investment trust focused on owning and managing healthcare-related properties across the United States. The company acquires, develops and leases a diversified portfolio of medical office buildings, outpatient facilities, long-term care centers and other specialized healthcare real estate. By concentrating on essential healthcare assets, Global Medical REIT seeks to generate stable, long-term rental income under triple-net and modified gross lease structures.

Since its incorporation in 2016 and initial public offering in 2017, the company has pursued an acquisitive growth strategy targeting markets with strong demographic trends and limited supply of modern medical facilities.

Read More

Insider Buying and Selling by Quarter for Global Medical REIT (NYSE:XRN)

Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.